About the conference

Asia’s most influential Pharmaceutical Congress continues to fulfill its promise. Packed with case studies from market leaders, three agendas will unite to create a hub of research, innovation, improved regulatory frameworks, best practice business, marketing and distribution models that will define Asia’s pharmaceutical future.

“This was a fantastic gathering and a very well organized event. Would love to attend this in the future. Keep up the good work”
Rahul Mongia, Research Associate, ICRIER

Programme at a Glance

 

10th Pharma Regulatory Affairs Asia

Continued changes in regulations, varied interpretation of guidelines, lack of transparency in processes and delayed timelines for approval are ongoing challenges being faced by the industry. The 10th Pharma Regulatory Affairs Asia will focus on learning from industry leaders on how to overcome regulatory implementation challenges, and develop strategies for efficient drug approvals for pharmaceutical, biopharmaceutical and medical device.

Accelerating Clinical Trials in Asia

The ONLY senior platform focused at clinical operational excellence Singapore, the Accelerating Clinical Trials in Asia zeroes in on the key operational and executional challenges in the burgeoning trial markets within Asia Pacific. Balanced with commercial information on Pharma spend areas and growth segments, this is your one stop shop to accelerate cost-efficient clinical development.

Pharma Market Access and Pricing Summit

IBC’s Pharma Market Access and Pricing conference focuses on profitable yet patient-centric market access strategies for Asia’s diverse markets, in the back of pricing and reimbursement approaches in specific countries. You will also gain insight from government’s views and direction towards pharma market access.